5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester manufacturers
|
| | 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester Basic information |
| Product Name: | 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester | | Synonyms: | 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester | | CAS: | 2252422-32-3 | | MF: | C26H38N2O10 | | MW: | 538.59 | | EINECS: | | | Product Categories: | | | Mol File: | 2252422-32-3.mol | ![5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester Structure](CAS/20200331/GIF/2252422-32-3.gif) |
| | 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester Chemical Properties |
| density | 1.28±0.1 g/cm3(Predicted) | | storage temp. | Storage temp. -20°C | | solubility | Soluble in DMSO, DCM, DMF | | pka | 12.05±0.46(Predicted) | | form | Liquid | | color | Colorless to light yellow |
| | 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester Usage And Synthesis |
| Description | endo-BCN-PEG4-NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. The BCN group enables copper free click chemistry with azide-tagged biomolecules. The hydrophilic PEG spacer increases solubility in aqueous media. | | Uses | endo-BCN-PEG4-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. endo-BCN-PEG4-NHS ester is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(bicyclo[6.1.0]non-4-yn-9-ylmethyl) 17-(2,5-dioxo-1-pyrrolidinyl) ester Preparation Products And Raw materials |
|